Respirerx Pharmaceuticals Inc Share Price OTC Bulletin Board
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Sales 2021 | - | Sales 2022 | - | Capitalization | 289K 24.14M |
---|---|---|---|---|---|
Net income 2021 | -3M -251M | Net income 2022 | -2M -167M | EV / Sales 2021 | - |
Net Debt 2021 | 2.08M 174M | Net Debt 2022 | 2.71M 226M | EV / Sales 2022 | - |
P/E ratio 2021 |
-0.29
x | P/E ratio 2022 |
-0.06
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 93.37% |
Managers | Title | Age | Since |
---|---|---|---|
Arnold Lippa
CEO | Chief Executive Officer | 77 | 22/13/22 |
Jeff Margolis
DFI | Director of Finance/CFO | 68 | 22/13/22 |
Richard Purcell
CTO | Chief Tech/Sci/R&D Officer | 63 | 15/14/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arnold Lippa
CEO | Chief Executive Officer | 77 | 22/13/22 |
Director/Board Member | - | 22/23/22 | |
Jeff Margolis
DFI | Director of Finance/CFO | 68 | 22/13/22 |
1st Jan change | Capi. | |
---|---|---|
+15.85% | 121B | |
+18.91% | 112B | |
+4.43% | 22.57B | |
-18.63% | 20.82B | |
-13.76% | 16.3B | |
-16.61% | 16.19B | |
-43.53% | 16.17B | |
+1.75% | 13.17B | |
+28.07% | 11.11B |